|NASDAQ: ALGN||Healthcare / Medical Devices & Instruments / USA|
|307.68||+0.9200||+0.30%||Vol 133.34K||1Y Perf 16.84%|
|Jun 9th, 2023 11:05 DELAYED|
|-0.76 -0.25%||- -|
|Target Price||269.33||Analyst Rating||Moderate Buy 1.55|
|Potential %||-12.24||Finscreener Ranking||★★★ 50.02|
|Insiders Trans % 3/6/12 mo.||100/100/-92||Value Ranking||★★ 45.82|
|Insiders Value % 3/6/12 mo.||100/100/-95||Growth Ranking||★★★★+ 65.52|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/-87||Income Ranking||— -|
|Price Range Ratio 52W %||68.91||Earnings Rating||Sell|
|Market Cap||23.54B||Earnings Date||26th Jul 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||26th Jul 2023|
|Estimated EPS Next Report||1.65|
|EPS Growth Next 5 Years %||17.20|
|Avg. Weekly Volume||522.71K|
|Avg. Monthly Volume||646.26K|
|Avg. Quarterly Volume||754.07K|
Align Technology Inc. (NASDAQ: ALGN) stock closed at 306.76 per share at the end of the most recent trading day (a 1.67% change compared to the prior day closing price) with a volume of 417.78K shares and market capitalization of 23.54B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 21590 people. Align Technology Inc. CEO is Joseph M. Hogan.
The one-year performance of Align Technology Inc. stock is 16.84%, while year-to-date (YTD) performance is 45.45%. ALGN stock has a five-year performance of -11.51%. Its 52-week range is between 172.05 and 368.87, which gives ALGN stock a 52-week price range ratio of 68.91%
Align Technology Inc. currently has a PE ratio of 34.10, a price-to-book (PB) ratio of 4.67, a price-to-sale (PS) ratio of 6.28, a price to cashflow ratio of 25.00, a PEG ratio of 2.32, a ROA of 9.55%, a ROC of 13.69% and a ROE of 15.31%. The company’s profit margin is 11.29%, its EBITDA margin is 22.60%, and its revenue ttm is $2.83 Billion , which makes it $36.27 revenue per share.
Of the last four earnings reports from Align Technology Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $1.65 for the next earnings report. Align Technology Inc.’s next earnings report date is 26th Jul 2023.
The consensus rating of Wall Street analysts for Align Technology Inc. is Moderate Buy (1.55), with a target price of $269.33, which is -12.24% compared to the current price. The earnings rating for Align Technology Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Align Technology Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Align Technology Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.01, ATR14 : 9.59, CCI20 : 118.60, Chaikin Money Flow : 0.14, MACD : -2.66, Money Flow Index : 53.21, ROC : 1.97, RSI : 54.10, STOCH (14,3) : 86.99, STOCH RSI : 1.00, UO : 61.15, Williams %R : -13.01), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Align Technology Inc. in the last 12-months were: Anne M. Myong (Buy at a value of $285 385), Coletti Julie (Option Excercise at a value of $0), Emory Wright (Option Excercise at a value of $0), Hockridge Stuart (Option Excercise at a value of $0), Hogan Joseph (Option Excercise at a value of $0), John F Morici (Buy at a value of $200 660), John F Morici (Option Excercise at a value of $0), John F. .Morici (Option Excercise at a value of $0), Joseph M. Hogan (Buy at a value of $2 998 899), Joseph M. Hogan (Option Excercise at a value of $0), Julie Ann Coletti (Option Excercise at a value of $0), Stuart A. Hockridge (Option Excercise at a value of $0), Warren S. Thaler (Buy at a value of $200 770), Wright Emory (Option Excercise at a value of $0)
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Strong Buy||Strong Buy||Strong Buy|
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
CEO: Joseph M. Hogan
Telephone: +1 408 470-1000
Address: 410 North Scottsdale Road, Tempe 85281, AZ, US
Number of employees: 21 590
Thu, 27 Apr 2023 13:05 GMT Align Tech (ALGN) Receives a Hold from Goldman Sachs- TipRanks. All rights reserved.
Thu, 27 Apr 2023 09:30 GMT Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Integra Lifesciences (IART) and Thermo Fisher (TMO)- TipRanks. All rights reserved.
Tue, 11 Apr 2023 12:20 GMT Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Shockwave Medical (SWAV) and Neogen (NEOG)- TipRanks. All rights reserved.
Thu, 02 Feb 2023 13:20 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (ALGN), Boston Scientific (BSX) and Evelo Biosciences (EVLO)- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.